| |
|
|
|
GenMark Diagnostics Inc.  
|
|
6.83 0.1 (0.01%) |
02-21 15:08 |
|
Open: |
6.73 |
Pre close: |
6.73 |
Target:
|
8.06 
|
|
High: |
6.9 |
Low: |
6.64 |
Resistance:
|
6.90
8.06
|
|
Volume: |
382,881 |
Market Cap: |
382M |
Support:
|
6.15
5.69
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.45
|
MACD |
MACD(12,26):
|
0.21 |
|
MA(20): |
6.23 |
Signal(12,26,9): |
0.18 |
|
MA(100): |
5.54  |
Stochastic Oscillator |
%K(14,3):
|
81.46 |
|
MA(250): |
6.20 |
%D(3): |
64.77 |
|
Average Volume(K) |
3-Month: |
39083
|
52-Week |
High:
|
8.81 |
|
10-Days: |
50933 |
Low: |
3.58 |
|
RSI |
RSI(14):
|
70.48 |
Change(%): |
61.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.970 |
Return on Equity (ttm) |
-88.0 |
Shares Out. (M) |
55.96 |
|
EPS Est. Current Year |
-1.070 |
Return on Assets (ttm) |
-48.9 |
Shares Float (M) |
52.81 |
|
EPS Est. Next Year |
-0.690 |
PEG Ratio |
0.16 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.140 |
Qtrly Rev. Growth |
36.1 |
% Held by Institutions |
150.70 |
|
Forward EPS |
-0.630 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
8.060 |
EBITDA (p.s.) |
0.000 |
P/E |
-7.07 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.85 |
|
Profit Margin |
-76.11 |
Operating Cash Flow
(M) |
-41.72 |
P/S |
314660352.00 |
|
Operating Margin |
-75.85 |
Levered Free Cash Flow
(M) |
-19.45 |
P/CF |
-9.20 |
|
|
|
|
|
|
